136 related articles for article (PubMed ID: 15381816)
21. Analysis of variants in the complement factor H, the elongation of very long chain fatty acids-like 4 and the hemicentin 1 genes of age-related macular degeneration in the Finnish population.
Seitsonen S; Lemmelä S; Holopainen J; Tommila P; Ranta P; Kotamies A; Moilanen J; Palosaari T; Kaarniranta K; Meri S; Immonen I; Järvelä I
Mol Vis; 2006 Jul; 12():796-801. PubMed ID: 16885922
[TBL] [Abstract][Full Text] [Related]
22. Genetics of host response in leprosy.
Moraes MO; Cardoso CC; Vanderborght PR; Pacheco AG
Lepr Rev; 2006 Sep; 77(3):189-202. PubMed ID: 17171999
[TBL] [Abstract][Full Text] [Related]
23. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
[TBL] [Abstract][Full Text] [Related]
24. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant.
Lu J; Wang LE; Xiong P; Sturgis EM; Spitz MR; Wei Q
Carcinogenesis; 2007 May; 28(5):988-94. PubMed ID: 17118968
[TBL] [Abstract][Full Text] [Related]
25. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW
Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
[TBL] [Abstract][Full Text] [Related]
27. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
28. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
Hoppe B; Häupl T; Gruber R; Kiesewetter H; Burmester GR; Salama A; Dörner T
Arthritis Res Ther; 2006; 8(2):R34. PubMed ID: 16469113
[TBL] [Abstract][Full Text] [Related]
29. Association of susceptibility to brucellosis and interleukin-4 promoter polymorphism.
Rezazadeh M; Hajilooi M; Haidari M; Rafiei A; Alavi SA; Keramat F
Scand J Infect Dis; 2006; 38(11-12):1045-9. PubMed ID: 17148075
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-1 gene cluster polymorphism in chagas disease in a Colombian case-control study.
Flórez O; Zafra G; Morillo C; Martín J; González CI
Hum Immunol; 2006 Sep; 67(9):741-8. PubMed ID: 17002905
[TBL] [Abstract][Full Text] [Related]
31. Estimating the relative recurrence risk ratio using a global cross-ratio model.
Wallace C; Clayton D
Genet Epidemiol; 2003 Dec; 25(4):293-302. PubMed ID: 14639699
[TBL] [Abstract][Full Text] [Related]
32. Genetic and immunological evidence implicates interleukin 6 as a susceptibility gene for leprosy type 2 reaction.
Sousa AL; Fava VM; Sampaio LH; Martelli CM; Costa MB; Mira MT; Stefani MM
J Infect Dis; 2012 May; 205(9):1417-24. PubMed ID: 22459738
[TBL] [Abstract][Full Text] [Related]
33. Association of the solute carrier family 11 member 1 gene polymorphisms with susceptibility to leprosy in a Brazilian sample.
Brochado MJ; Gatti MF; Zago MA; Roselino AM
Mem Inst Oswaldo Cruz; 2016 Feb; 111(2):101-5. PubMed ID: 26814595
[TBL] [Abstract][Full Text] [Related]
34. Geographic determinants of leprosy in Karonga District, Northern Malawi.
Sterne JA; Pönnighaus JM; Fine PE; Malema SS
Int J Epidemiol; 1995 Dec; 24(6):1211-22. PubMed ID: 8824865
[TBL] [Abstract][Full Text] [Related]
35. Extended schooling and good housing conditions are associated with reduced risk of leprosy in rural Malawi.
Ponnighaus JM; Fine PE; Sterne JA; Malema SS; Bliss L; Wilson RJ
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):345-52. PubMed ID: 7963906
[TBL] [Abstract][Full Text] [Related]
36. VDR gene polymorphism at exon 2 start codon (FokI) may have influenced Type 1 diabetes mellitus susceptibility in two Spanish populations.
Audí L; Martí G; Esteban C; Oyarzabal M; Chueca M; Gussinyé M; Yeste D; Fernández-Cancio M; Andaluz P; Carrascosa A
Diabet Med; 2004 Apr; 21(4):393-4. PubMed ID: 15049946
[No Abstract] [Full Text] [Related]
37. Complement receptor 1 (CR1, CD35) association with susceptibility to leprosy.
Kretzschmar GC; Oliveira LC; Nisihara RM; Velavan TP; Stinghen ST; Stahlke ERS; Petzl-Erler ML; Messias-Reason IJT; Boldt ABW
PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006705. PubMed ID: 30092084
[TBL] [Abstract][Full Text] [Related]
38. Genetics of susceptibility to leprosy.
Fitness J; Tosh K; Hill AV
Genes Immun; 2002 Dec; 3(8):441-53. PubMed ID: 12486602
[TBL] [Abstract][Full Text] [Related]
39. [Leprosy: a paradigm for the study of human genetic susceptibility to infectious diseases].
Ranque B; Alter A; Schurr E; Abel L; Alcais A
Med Sci (Paris); 2008 May; 24(5):491-7. PubMed ID: 18466726
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide association study of leprosy in Malawi and Mali.
Gilchrist JJ; Auckland K; Parks T; Mentzer AJ; Goldblatt L; Naranbhai V; Band G; Rockett KA; Toure OB; Konate S; Sissoko S; Djimdé AA; Thera MA; Doumbo OK; Sow S; Floyd S; Pönnighaus JM; Warndorff DK; Crampin AC; Fine PEM; Fairfax BP; Hill AVS
PLoS Pathog; 2022 Sep; 18(9):e1010312. PubMed ID: 36121873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
